14-day Premium Trial Subscription Sign Up For FreeGet Free

Anavex Life Sciences Corp. Stock Forecast NASDAQ:AVXL

Price Target and Analyst Ratings

Most Recent Rating

On September 23, 2021 "BTIG Research" gave "$35.00" rating for AVXL. The price target was set to $17.64+1.4%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-23 $35.00 Initiated by BTIG Research $19.29 $17.64+1.4%
2021-06-28 Buy Target Raised by HC Wainwright $28.86 $25.00 → $39.00
2021-06-28 Overweight Target Raised by Cantor Fitzgerald $28.86 $31.00 → $40.00
2021-06-28 Buy Reiterated by HC Wainwright $28.86 $25.00 → $39.00
2021-06-21 Buy Target Raised by Dawson James $25.17 $19.00 → $35.00
2021-06-15 Buy Target Raised by HC Wainwright $17.34 $17.00 → $25.00
2021-06-15 Buy Reiterated by HC Wainwright $17.34 $17.00 → $25.00
2021-06-14 Buy Reiterated by Jonestrading $20.99 $35.00
2021-03-01 Overweight Reiterated by Cantor Fitzgerald $12.94 $10.00 → $25.00
2021-02-23 Overweight Target Raised by Cantor Fitzgerald $12.07 $10.00 → $25.00
2021-02-23 Overweight Reiterated by Cantor Fitzgerald $12.07
2021-02-17 Buy Reiterated by LADENBURG THALM/SH SH $12.73 $20.00
2020-12-16 Buy Target Raised by HC Wainwright $5.80 $14.00 → $17.00
2020-10-21 Buy Target Raised by HC Wainwright $5.15 $12.00 → $14.00
2020-09-28 Buy Initiated by LADENBURG THALM/SH SH $4.66 $12.00
2020-08-11 Buy Reiterated by HC Wainwright $3.93
2020-06-16 Buy Reiterated by HC Wainwright $4.15 $12.00
2020-06-08 Buy Reiterated by Dawson James $4.06 $16.00
2020-06-08 Buy Reiterated by Janney Montgomery Scott $4.06 $10.00
2020-06-08 Buy Reiterated by Cantor Fitzgerald $4.06 $8.00
2020-05-22 Buy Reiterated by HC Wainwright $4.24 $12.00
2020-05-08 Buy Reiterated by HC Wainwright $3.48 $12.00

AVXL Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -24.97% during the next 3 months and, with a 90% probability hold a price between $11.84 and $14.85 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-30 $15.67 $17.68 $19.69
2021-10-01 $15.57 $17.57 $19.58
2021-10-04 $15.46 $17.47 $19.48
2021-10-05 $15.36 $17.36 $19.37
2021-10-06 $15.25 $17.26 $19.27
2021-10-07 $15.15 $17.15 $19.16
2021-10-08 $15.04 $17.05 $19.06
2021-10-11 $14.94 $16.95 $18.95
2021-10-12 $14.83 $16.84 $18.85
2021-10-13 $14.73 $16.74 $18.74
2021-10-14 $14.62 $16.63 $18.64
2021-10-15 $14.52 $16.53 $18.54
2021-10-18 $14.42 $16.42 $18.43
2021-10-19 $14.31 $16.32 $18.33
2021-10-20 $14.21 $16.21 $18.22
2021-10-21 $14.10 $16.11 $18.12
2021-10-22 $14.00 $16.00 $18.01
2021-10-25 $13.89 $15.90 $17.91
2021-10-26 $13.79 $15.80 $17.80
2021-10-27 $13.68 $15.69 $17.70
2021-10-28 $13.58 $15.59 $17.59
2021-10-29 $13.47 $15.48 $17.49
2021-11-01 $13.37 $15.38 $17.39
2021-11-02 $13.26 $15.27 $17.28
2021-11-03 $13.16 $15.17 $17.18
2021-11-04 $13.06 $15.06 $17.07
2021-11-05 $12.95 $14.96 $16.97
2021-11-08 $12.85 $14.85 $16.86
2021-11-09 $12.74 $14.75 $16.76
2021-11-10 $12.64 $14.65 $16.65

About Anavex Life Sciences Corp.

Anavex Life Sciences Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimer’s disease, other central nervous system diseases, pain, and various cancers. The company’s lead drug candidates include ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil, which is in a Phase 2a clinical trial for the treatment of Alzheimer’s and other central nervous system ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT